Differential sensitivity of children and adults to chemical toxicity - II. Risk and regulation

被引:60
作者
Dourson, M
Charnley, G
Scheuplein, R
机构
[1] Toxicol Excellence Risk Assessment, Cincinnati, OH 45223 USA
[2] HealthRisk Strategies, Washington, DC 20003 USA
[3] Keller & Heckman, Stafford, VA 22554 USA
关键词
D O I
10.1006/rtph.2002.1559
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Animals can be useful predictors of chemical hazards to humans. Growth and development are compressed into a shorter period in animals, which makes interpretation of animal testing inherently more difficult. However, similar events occur in both humans and laboratory animals and testing that covers the full period of animal development can reasonably be considered an appropriate surrogate for human development. Some have proposed an additional 10-fold factor for the extra protection of children when estimating safe exposures. Use of such an additional factor, as required by the Food Quality Protection Act (FQPA), is meant to address the same issues covered by the EPA's database uncertainty factor, UFD, and additional issues related to exposure uncertainty. Thus, when UFD has already been deployed, the EPA modifies its use of the FQPA factor. Based on our analysis, we agree with the EPA. Drawing conclusions about the adequacy of UFH, the uncertainty factor used to account for intrahuman variability, in terms of its ability to protect children on the basis of the modest data available is challenging. However, virtually all studies available suggest that a high percentage of the population, including children, is protected by using a 10-fold uncertainty factor for human variability or by using a 3.16-fold factor each for toxicokinetic and toxicodynamic variability. Based on specific comparisons for newborns, infants, children, adults, and those with severe disease, the population protected is between 60 and 100%, with the studies in larger populations that include sensitive individuals suggesting that the value is closer to 100%. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:448 / 467
页数:20
相关论文
共 50 条
[1]  
[Anonymous], 1998, RETROSPECTIVE ANAL 1
[2]  
[Anonymous], DET APPR FQPA SAF FA
[3]  
[Anonymous], 1998, QUANTIFICATION EXTRA
[4]   Noncancer risk assessment: A probabilistic alternative to current practice [J].
Baird, SJS ;
Cohen, JT ;
Graham, JD ;
Shlyakhter, AI ;
Evans, JS .
HUMAN AND ECOLOGICAL RISK ASSESSMENT, 1996, 2 (01) :79-102
[5]   REFERENCE DOSE (RFD) - DESCRIPTION AND USE IN HEALTH RISK ASSESSMENTS [J].
BARNES, DG ;
DOURSON, M .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (04) :471-486
[6]  
BROCK A, 1991, BRIT J IND MED, V48, P562
[7]   Risk assessment around the country: A forum for risk assessment information and analysis developed to inform regional, state, and local policy decisions [J].
Brown, DR .
HUMAN AND ECOLOGICAL RISK ASSESSMENT, 2001, 7 (01) :209-213
[8]   Differences in sensitivity of children and adults to chemical toxicity: The NAS panel report [J].
Bruckner, JV .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2000, 31 (03) :280-285
[9]   Addressing human variability in risk assessment - The robustness of the intraspecies uncertainty factor [J].
Burin, GJ ;
Saunders, DR .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1999, 30 (03) :209-216
[10]   UNCERTAINTY FACTORS AND INTERINDIVIDUAL VARIATION [J].
CALABRESE, EJ .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1985, 5 (02) :190-196